Hospital Quironsalud Malaga

The department focuses on non‑small cell lung cancer, breast cancer, melanoma and other solid tumors, aiming to test new targeted agents, immunotherapy combinations and antibody‑drug conjugates to improve survival and disease control.

• Immunotherapy‑based combination trials
• Antibody‑drug conjugate efficacy studies
• Targeted therapy for EGFR‑mutated lung cancer
• Adjuvant treatments after surgical resection

With 62 active trials and 33 investigators, Hospital Quironsalud Malaga is a leading hub for innovative cancer research in southern Europe.

Trials address acute myocardial infarction, atherosclerotic cardiovascular disease, severe hypertriglyceridemia, obesity and overweight, exploring lipid‑lowering agents, cardioprotective drugs and weight‑management strategies to reduce cardiovascular risk.

• Novel triglyceride‑lowering therapies
• Cardiovascular outcome trials in ASCVD
• Weight‑loss interventions for obesity‑related heart disease
• Early‑intervention strategies after myocardial infarction

The site integrates endocrinology and nutrition expertise to evaluate metabolic health alongside heart disease.

Research includes patients with Alzheimer's dementia‑related agitation, psychosis, and schizophrenia, testing novel antipsychotics, symptom‑targeted agents and cognitive‑support therapies to enhance patient well‑being.

• Anti‑agitation compounds for dementia
• Negative‑symptom treatments in schizophrenia
• Long‑term safety of psychosis‑targeted drugs
• Combination approaches with standard care

These studies aim to provide safer, more effective options for neuropsychiatric conditions.

The site evaluates therapies for chronic cough, allergic rhinitis, asthma and related airway disorders, focusing on novel cough modulators, allergen immunotherapy and anti‑inflammatory agents to improve respiratory function.

• Cough‑frequency reduction trials
• Allergen‑specific immunotherapy for house‑dust‑mite allergy
• Biologic treatments for severe asthma
• Patient‑reported outcome measures in respiratory disease

Collaborative efforts with pulmonology enhance the breadth of respiratory investigations.

Studies target cytomegalovirus, meningococcal infection, bacterial and fungal diseases, and vaccine safety, evaluating antiviral agents, novel antibiotics and immunogenicity of next‑generation vaccines.

• Antiviral efficacy in CMV prevention
• Safety and reactogenicity of multivalent meningococcal vaccines
• New antimicrobial regimens for resistant infections
• Immune response profiling in vaccine trials

These trials support public health goals by advancing therapeutic and preventive options.

Research includes participants with knee osteoarthritis, overweight, and related joint disorders, testing weight‑loss drugs, pain‑relief agents and disease‑modifying therapies to improve mobility and quality of life.

• Weight‑reduction compounds for obese OA patients
• Analgesic efficacy of novel topical agents
• Structural outcomes in osteoarthritis progression
• Integrated lifestyle and pharmacologic interventions

The multidisciplinary approach combines endocrinology, nutrition and orthopedics to address musculoskeletal health.